HEADER DNA BINDING PROTEIN 31-OCT-17 6EUT TITLE THE TRANSCRIPTIONAL REGULATOR PRFA FROM LISTERIA MONOCYTOGENES IN TITLE 2 COMPLEX WITH A RING-FUSED 2-PYRIDONE (KSK67) COMPND MOL_ID: 1; COMPND 2 MOLECULE: LISTERIOLYSIN REGULATORY PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: LISTERIA MONOCYTOGENES EGD-E; SOURCE 3 ORGANISM_TAXID: 169963; SOURCE 4 GENE: PRFA, LMO0200; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSCRIPTION REGULATOR, DNA BINDING, 2-PYRIDONE, DRUG DESIGN, KEYWDS 2 LISTERIA MONOCYTOGENES, DNA BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR A.BEGUM,M.HALL,C.GRUNDSTROM,M.KULEN,M.LINDGREN,J.JOHANSSON, AUTHOR 2 F.ALMQVIST,U.H.SAUER,A.E.SAUER-ERIKSSON REVDAT 3 17-JAN-24 6EUT 1 LINK REVDAT 2 23-MAY-18 6EUT 1 JRNL REVDAT 1 02-MAY-18 6EUT 0 JRNL AUTH M.KULEN,M.LINDGREN,S.HANSEN,A.G.CAIRNS,C.GRUNDSTROM,A.BEGUM, JRNL AUTH 2 I.VAN DER LINGEN,K.BRANNSTROM,M.HALL,U.H.SAUER,J.JOHANSSON, JRNL AUTH 3 A.E.SAUER-ERIKSSON,F.ALMQVIST JRNL TITL STRUCTURE-BASED DESIGN OF INHIBITORS TARGETING PRFA, THE JRNL TITL 2 MASTER VIRULENCE REGULATOR OF LISTERIA MONOCYTOGENES. JRNL REF J. MED. CHEM. V. 61 4165 2018 JRNL REFN ISSN 1520-4804 JRNL PMID 29667825 JRNL DOI 10.1021/ACS.JMEDCHEM.8B00289 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.A.GOOD,C.ANDERSSON,S.HANSEN,J.WALL,K.S.KRISHNAN,A.BEGUM, REMARK 1 AUTH 2 C.GRUNDSTROM,M.S.NIEMIEC,K.VAITKEVICIUS,E.CHORELL, REMARK 1 AUTH 3 P.WITTUNG-STAFSHEDE,U.H.SAUER,A.E.SAUER-ERIKSSON,F.ALMQVIST, REMARK 1 AUTH 4 J.JOHANSSON REMARK 1 TITL ATTENUATING LISTERIA MONOCYTOGENES VIRULENCE BY TARGETING REMARK 1 TITL 2 THE REGULATORY PROTEIN PRFA. REMARK 1 REF CELL CHEM BIOL V. 23 404 2016 REMARK 1 REFN ESSN 2451-9456 REMARK 1 PMID 26991105 REMARK 1 DOI 10.1016/J.CHEMBIOL.2016.02.013 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10.1_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.34 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 40038 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.182 REMARK 3 R VALUE (WORKING SET) : 0.179 REMARK 3 FREE R VALUE : 0.228 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.950 REMARK 3 FREE R VALUE TEST SET COUNT : 1983 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.3563 - 4.5778 1.00 2931 138 0.1618 0.1857 REMARK 3 2 4.5778 - 3.6341 1.00 2780 147 0.1514 0.2087 REMARK 3 3 3.6341 - 3.1748 1.00 2742 141 0.1770 0.2405 REMARK 3 4 3.1748 - 2.8846 1.00 2719 155 0.1919 0.2390 REMARK 3 5 2.8846 - 2.6779 1.00 2702 144 0.1855 0.2246 REMARK 3 6 2.6779 - 2.5200 1.00 2681 159 0.1928 0.2458 REMARK 3 7 2.5200 - 2.3938 1.00 2705 141 0.1886 0.2376 REMARK 3 8 2.3938 - 2.2896 1.00 2678 135 0.1813 0.2561 REMARK 3 9 2.2896 - 2.2015 1.00 2722 139 0.1888 0.2250 REMARK 3 10 2.2015 - 2.1255 1.00 2712 135 0.2047 0.2446 REMARK 3 11 2.1255 - 2.0591 1.00 2666 127 0.2079 0.3066 REMARK 3 12 2.0591 - 2.0002 1.00 2685 143 0.2166 0.2541 REMARK 3 13 2.0002 - 1.9476 1.00 2665 152 0.2317 0.2910 REMARK 3 14 1.9476 - 1.9000 1.00 2667 127 0.2358 0.2546 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.230 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.420 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.012 3984 REMARK 3 ANGLE : 1.130 5392 REMARK 3 CHIRALITY : 0.064 584 REMARK 3 PLANARITY : 0.007 665 REMARK 3 DIHEDRAL : 13.759 2344 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6EUT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 31-OCT-17. REMARK 100 THE DEPOSITION ID IS D_1200007278. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-DEC-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.975 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40105 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 47.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.100 REMARK 200 R MERGE (I) : 0.05800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.94 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 6.40 REMARK 200 R MERGE FOR SHELL (I) : 0.50400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 5F1R REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PRFA WAS CO-CRYSTALLIZED WITH COMPLEX REMARK 280 (5 MOL EXCESS) USING THE HANGING-DROP VAPOR-DIFFUSION TECHNIQUE. REMARK 280 CRYSTALS GREW IN 5 DAYS AFTER 2 MICROL OF THE PROTEIN SOLUTION REMARK 280 (3.2-3.5 MG PER ML PRFA, 200 MM NACL, 20 MM NAP BUFFER, PH 6.5) REMARK 280 WAS MIXED WITH AN EQUAL VOLUME OF PRECIPITANT SOLUTION REMARK 280 CONTAINING 20-24% PEG-4000, 17% ISOPROPANOL, 100 MM NA CITRATE REMARK 280 PH 5.5 AND ALLOWED TO EQUILIBRATE OVER A 1 ML SOLUTION OF THE REMARK 280 PRECIPITANT IN A LINBRO PLATE (HAMPTON RESEARCH)., VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.96700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 58.39400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.35500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 58.39400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.96700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.35500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5110 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19920 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -58.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 ALA A 0 REMARK 465 MET A 1 REMARK 465 GLY B -1 REMARK 465 ALA B 0 REMARK 465 MET B 1 REMARK 465 SER B 177 REMARK 465 SER B 178 REMARK 465 GLY B 179 REMARK 465 ILE B 180 REMARK 465 ALA B 181 REMARK 465 HIS B 182 REMARK 465 SER B 183 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 25 -7.21 85.03 REMARK 500 ASN A 109 108.14 -164.04 REMARK 500 ASN A 109 108.14 -161.28 REMARK 500 LEU A 169 -72.17 -57.88 REMARK 500 LYS B 25 -7.99 88.45 REMARK 500 ASP B 167 133.57 -32.91 REMARK 500 ASP B 167 133.50 -32.91 REMARK 500 ASN B 203 23.19 45.99 REMARK 500 CYS B 205 -163.97 -105.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 302 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 30 O REMARK 620 2 GLU A 36 OE1 176.8 REMARK 620 3 HOH A 404 O 94.7 87.0 REMARK 620 4 HOH A 438 O 86.0 96.2 105.6 REMARK 620 5 HOH A 464 O 96.4 80.4 119.6 134.3 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA B 302 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN B 30 O REMARK 620 2 GLU B 36 OE1 174.7 REMARK 620 3 HOH B 402 O 105.3 77.1 REMARK 620 4 HOH B 433 O 101.0 73.9 125.6 REMARK 620 5 HOH B 454 O 90.8 93.6 95.7 130.8 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue BY8 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NA A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue IPA A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue BY8 B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NA B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 303 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5F1R RELATED DB: PDB REMARK 900 5F1R CONTAINS THE SAME PROTEIN IN COMPLEX WITH COMPOUND 1 (C10) DBREF 6EUT A 1 237 UNP P22262 PRFA_LISMO 1 237 DBREF 6EUT B 1 237 UNP P22262 PRFA_LISMO 1 237 SEQADV 6EUT GLY A -1 UNP P22262 EXPRESSION TAG SEQADV 6EUT ALA A 0 UNP P22262 EXPRESSION TAG SEQADV 6EUT GLY B -1 UNP P22262 EXPRESSION TAG SEQADV 6EUT ALA B 0 UNP P22262 EXPRESSION TAG SEQRES 1 A 239 GLY ALA MET ASN ALA GLN ALA GLU GLU PHE LYS LYS TYR SEQRES 2 A 239 LEU GLU THR ASN GLY ILE LYS PRO LYS GLN PHE HIS LYS SEQRES 3 A 239 LYS GLU LEU ILE PHE ASN GLN TRP ASP PRO GLN GLU TYR SEQRES 4 A 239 CYS ILE PHE LEU TYR ASP GLY ILE THR LYS LEU THR SER SEQRES 5 A 239 ILE SER GLU ASN GLY THR ILE MET ASN LEU GLN TYR TYR SEQRES 6 A 239 LYS GLY ALA PHE VAL ILE MET SER GLY PHE ILE ASP THR SEQRES 7 A 239 GLU THR SER VAL GLY TYR TYR ASN LEU GLU VAL ILE SER SEQRES 8 A 239 GLU GLN ALA THR ALA TYR VAL ILE LYS ILE ASN GLU LEU SEQRES 9 A 239 LYS GLU LEU LEU SER LYS ASN LEU THR HIS PHE PHE TYR SEQRES 10 A 239 VAL PHE GLN THR LEU GLN LYS GLN VAL SER TYR SER LEU SEQRES 11 A 239 ALA LYS PHE ASN ASP PHE SER ILE ASN GLY LYS LEU GLY SEQRES 12 A 239 SER ILE CYS GLY GLN LEU LEU ILE LEU THR TYR VAL TYR SEQRES 13 A 239 GLY LYS GLU THR PRO ASP GLY ILE LYS ILE THR LEU ASP SEQRES 14 A 239 ASN LEU THR MET GLN GLU LEU GLY TYR SER SER GLY ILE SEQRES 15 A 239 ALA HIS SER SER ALA VAL SER ARG ILE ILE SER LYS LEU SEQRES 16 A 239 LYS GLN GLU LYS VAL ILE VAL TYR LYS ASN SER CYS PHE SEQRES 17 A 239 TYR VAL GLN ASN LEU ASP TYR LEU LYS ARG TYR ALA PRO SEQRES 18 A 239 LYS LEU ASP GLU TRP PHE TYR LEU ALA CYS PRO ALA THR SEQRES 19 A 239 TRP GLY LYS LEU ASN SEQRES 1 B 239 GLY ALA MET ASN ALA GLN ALA GLU GLU PHE LYS LYS TYR SEQRES 2 B 239 LEU GLU THR ASN GLY ILE LYS PRO LYS GLN PHE HIS LYS SEQRES 3 B 239 LYS GLU LEU ILE PHE ASN GLN TRP ASP PRO GLN GLU TYR SEQRES 4 B 239 CYS ILE PHE LEU TYR ASP GLY ILE THR LYS LEU THR SER SEQRES 5 B 239 ILE SER GLU ASN GLY THR ILE MET ASN LEU GLN TYR TYR SEQRES 6 B 239 LYS GLY ALA PHE VAL ILE MET SER GLY PHE ILE ASP THR SEQRES 7 B 239 GLU THR SER VAL GLY TYR TYR ASN LEU GLU VAL ILE SER SEQRES 8 B 239 GLU GLN ALA THR ALA TYR VAL ILE LYS ILE ASN GLU LEU SEQRES 9 B 239 LYS GLU LEU LEU SER LYS ASN LEU THR HIS PHE PHE TYR SEQRES 10 B 239 VAL PHE GLN THR LEU GLN LYS GLN VAL SER TYR SER LEU SEQRES 11 B 239 ALA LYS PHE ASN ASP PHE SER ILE ASN GLY LYS LEU GLY SEQRES 12 B 239 SER ILE CYS GLY GLN LEU LEU ILE LEU THR TYR VAL TYR SEQRES 13 B 239 GLY LYS GLU THR PRO ASP GLY ILE LYS ILE THR LEU ASP SEQRES 14 B 239 ASN LEU THR MET GLN GLU LEU GLY TYR SER SER GLY ILE SEQRES 15 B 239 ALA HIS SER SER ALA VAL SER ARG ILE ILE SER LYS LEU SEQRES 16 B 239 LYS GLN GLU LYS VAL ILE VAL TYR LYS ASN SER CYS PHE SEQRES 17 B 239 TYR VAL GLN ASN LEU ASP TYR LEU LYS ARG TYR ALA PRO SEQRES 18 B 239 LYS LEU ASP GLU TRP PHE TYR LEU ALA CYS PRO ALA THR SEQRES 19 B 239 TRP GLY LYS LEU ASN HET BY8 A 301 28 HET NA A 302 1 HET IPA A 303 4 HET BY8 B 301 28 HET NA B 302 1 HET GOL B 303 6 HETNAM BY8 (3~{R})-8-CYCLOPROPYL-7-[(4-METHYLNAPHTHALEN-1-YL) HETNAM 2 BY8 METHYL]-5-OXIDANYLIDENE-2,3-DIHYDRO-[1,3]THIAZOLO[3,2- HETNAM 3 BY8 A]PYRIDINE-3-CARBOXYLIC ACID HETNAM NA SODIUM ION HETNAM IPA ISOPROPYL ALCOHOL HETNAM GOL GLYCEROL HETSYN IPA 2-PROPANOL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 BY8 2(C23 H21 N O3 S) FORMUL 4 NA 2(NA 1+) FORMUL 5 IPA C3 H8 O FORMUL 8 GOL C3 H8 O3 FORMUL 9 HOH *243(H2 O) HELIX 1 AA1 ASN A 2 ASN A 15 1 14 HELIX 2 AA2 ILE A 99 LYS A 108 1 10 HELIX 3 AA3 ASN A 109 TYR A 154 1 46 HELIX 4 AA4 ASP A 167 TYR A 176 1 10 HELIX 5 AA5 SER A 183 GLU A 196 1 14 HELIX 6 AA6 ASN A 210 ALA A 218 1 9 HELIX 7 AA7 ALA A 218 CYS A 229 1 12 HELIX 8 AA8 CYS A 229 LEU A 236 1 8 HELIX 9 AA9 ALA B 3 ASN B 15 1 13 HELIX 10 AB1 ILE B 99 ASN B 109 1 11 HELIX 11 AB2 ASN B 109 TYR B 154 1 46 HELIX 12 AB3 ASP B 167 LEU B 174 1 8 HELIX 13 AB4 ALA B 185 GLN B 195 1 11 HELIX 14 AB5 ASN B 210 ALA B 218 1 9 HELIX 15 AB6 ALA B 218 CYS B 229 1 12 HELIX 16 AB7 CYS B 229 GLY B 234 1 6 HELIX 17 AB8 LYS B 235 ASN B 237 5 3 SHEET 1 AA1 4 LYS A 20 HIS A 23 0 SHEET 2 AA1 4 GLN A 91 LYS A 98 -1 O ALA A 94 N LYS A 20 SHEET 3 AA1 4 TYR A 37 ASP A 43 -1 N CYS A 38 O ILE A 97 SHEET 4 AA1 4 PHE A 67 MET A 70 -1 O ILE A 69 N ILE A 39 SHEET 1 AA2 4 LEU A 27 PHE A 29 0 SHEET 2 AA2 4 ASN A 84 VAL A 87 -1 O LEU A 85 N ILE A 28 SHEET 3 AA2 4 ILE A 45 ILE A 51 -1 N LYS A 47 O GLU A 86 SHEET 4 AA2 4 ILE A 57 LYS A 64 -1 O GLN A 61 N LEU A 48 SHEET 1 AA3 4 GLY A 155 THR A 158 0 SHEET 2 AA3 4 GLY A 161 ILE A 164 -1 O LYS A 163 N LYS A 156 SHEET 3 AA3 4 CYS A 205 VAL A 208 -1 O VAL A 208 N ILE A 162 SHEET 4 AA3 4 ILE A 199 LYS A 202 -1 N LYS A 202 O CYS A 205 SHEET 1 AA4 4 LYS B 20 HIS B 23 0 SHEET 2 AA4 4 GLN B 91 LYS B 98 -1 O ALA B 92 N PHE B 22 SHEET 3 AA4 4 TYR B 37 ASP B 43 -1 N CYS B 38 O ILE B 97 SHEET 4 AA4 4 PHE B 67 MET B 70 -1 O ILE B 69 N ILE B 39 SHEET 1 AA5 3 ILE B 57 LYS B 64 0 SHEET 2 AA5 3 ILE B 45 ILE B 51 -1 N LEU B 48 O LEU B 60 SHEET 3 AA5 3 ASN B 84 VAL B 87 -1 O GLU B 86 N LYS B 47 SHEET 1 AA6 4 GLY B 155 THR B 158 0 SHEET 2 AA6 4 GLY B 161 ILE B 164 -1 O GLY B 161 N THR B 158 SHEET 3 AA6 4 TYR B 207 VAL B 208 -1 O VAL B 208 N ILE B 162 SHEET 4 AA6 4 ILE B 199 VAL B 200 -1 N VAL B 200 O TYR B 207 LINK O ASN A 30 NA NA A 302 1555 1555 2.43 LINK OE1 GLU A 36 NA NA A 302 1555 1555 2.78 LINK NA NA A 302 O HOH A 404 1555 1555 2.17 LINK NA NA A 302 O HOH A 438 1555 1555 2.52 LINK NA NA A 302 O HOH A 464 1555 1555 2.34 LINK O ASN B 30 NA NA B 302 1555 1555 2.55 LINK OE1 GLU B 36 NA NA B 302 1555 1555 2.94 LINK NA NA B 302 O HOH B 402 1555 1555 2.16 LINK NA NA B 302 O HOH B 433 1555 1555 2.40 LINK NA NA B 302 O HOH B 454 1555 1555 2.51 CISPEP 1 GLY A 65 ALA A 66 0 4.90 CISPEP 2 GLY B 65 ALA B 66 0 1.87 SITE 1 AC1 13 GLN A 61 TYR A 62 TYR A 63 LYS A 64 SITE 2 AC1 13 PHE A 67 TYR A 126 GLN A 146 ILE A 149 SITE 3 AC1 13 VAL A 153 TRP A 224 HOH A 412 HOH A 463 SITE 4 AC1 13 HOH A 480 SITE 1 AC2 6 ASN A 30 ASP A 33 GLU A 36 HOH A 404 SITE 2 AC2 6 HOH A 438 HOH A 464 SITE 1 AC3 4 TYR A 63 MET A 70 GLN A 123 LEU B 128 SITE 1 AC4 12 GLN B 61 TYR B 62 TYR B 63 LYS B 64 SITE 2 AC4 12 PHE B 67 LYS B 122 TYR B 126 GLN B 146 SITE 3 AC4 12 LEU B 150 TRP B 224 CYS B 229 HOH B 401 SITE 1 AC5 6 ASN B 30 ASP B 33 GLU B 36 HOH B 402 SITE 2 AC5 6 HOH B 433 HOH B 454 SITE 1 AC6 9 SER A 125 LEU A 128 TYR B 63 ILE B 69 SITE 2 AC6 9 MET B 70 VAL B 80 GLN B 123 HOH B 403 SITE 3 AC6 9 HOH B 410 CRYST1 47.934 88.710 116.788 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020862 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011273 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008563 0.00000